Biomarker Guided Treatment in Gynaecological Cancer
NCT02543710
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
1300
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
PROCEDURE:
Biomarker (ER/PR) guided lymphadenectomy
DRUG:
Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer
Sponsor
Haukeland University Hospital